Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Cytokeratin 13 Antikörper

Dieser Maus Monoklonal Antikörper erkennt spezifisch Cytokeratin 13 in IF, FACS und IHC (f). Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN6937655
-15% Promotion 2026
543,53 €
639,45 €
Sparen Sie 95,92 € (-15 %)
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 6 bis 9 Werktagen

Kurzübersicht für Cytokeratin 13 Antikörper (ABIN6937655)

Target

Alle Cytokeratin 13 (KRT13) Antikörper anzeigen
Cytokeratin 13 (KRT13) (Keratin 13 (KRT13))

Reaktivität

  • 103
  • 48
  • 33
  • 11
  • 6
  • 5
  • 4
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 76
  • 30
  • 1
  • 1
Maus

Klonalität

  • 58
  • 50
Monoklonal

Konjugat

  • 56
  • 5
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser Cytokeratin 13 Antikörper ist unkonjugiert

Applikation

  • 71
  • 51
  • 25
  • 20
  • 18
  • 17
  • 17
  • 13
  • 10
  • 8
  • 7
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Immunofluorescence (IF), Flow Cytometry (FACS), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))

Klon

KRT13-2213
  • Spezifität

    Cytokeratin 13 (KRT13) is the major acidic keratin, which together with KRT4, its basic partner, is expressed in the suprabasal layers of non-cornified stratified epithelia including tongue mucosa, esophagus, anal canal epithelium, tracheal epithelium, uterine cervix, and urothelium. Defects in the KRT13 gene are a cause of white sponge nevus of cannon (WSN), a rare autosomal dominant disorder, which predominantly affects non-cornified stratified squamous epithelia and is characterized by the presence of soft, white and spongy plaques in the oral mucosa. KRT13 has been used as a marker for non-keratinized squamous epithelium. It is also expressed in various squamous metaplasia, but it is down regulated in squamous dysplasia and squamous carcinoma.

    Kreuzreaktivität (Details)

    Human.

    Aufreinigung

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Recombinant full-length human KRT13 protein

    Isotyp

    IgG
  • Applikationshinweise

    Known_Application: Immunofluorescence (1-2 μg/mL), Flow Cytometry (1-2 μg per million cells), Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 min at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes), Optimal dilution for a specific application should be determined.

    Positive_Control: HeLa or A431 cells. Skin or squamous cell carcinoma.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Konservierungsmittel

    Azide free

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Haltbarkeit

    24 months
  • Target

    Cytokeratin 13 (KRT13) (Keratin 13 (KRT13))

    Andere Bezeichnung

    KRT13

    Hintergrund

    CK13, Cytokeratin-13, Keratin Type I Cytoskeletal 13, Keratin-13, KRT13, Type I Cytoskeletal 13, WSN2,Cytokeratin 13 (Non-Keratinized Squamous Epithelial Marker)
    Cellular localisation: Cytoplasmic

    Molekulargewicht

    52kDa

    Gen-ID

    3860, 654550

    UniProt

    P13646
Sie sind hier:
Chat with us!